Compugen | CGEN - Des Atouts





Des Atouts Changement Date
Arca Biopharma USD 504.48M 15.86M 2026-03
aTyr Pharma USD 79.65M 435.68M 2026-03
Bio Path USD 677K 13K 2026-03
Brainstorm Cell Therapeutics USD 755K 267K 2026-03
Cara Therapeutics USD 32.07M 6.95M 2025-12
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
Immunic USD 189.74M 165.69M 2026-03
Infinity Pharmaceuticals USD 21.23M 8.72M 2023-06
Minerva Neurosciences USD 97.97M 69.88M 2025-12
RedHill Biopharma USD 25.34M 6.97M 2025-12
TherapeuticsMD USD 40.13M 1.96M 2024-06